WGU D116 ADVANCED PHARMACOLOGY OA 400 ACTUAL
QUESTIONS AND VERIFIED ANSWERS WITH RATIONALES
ALREADY A+ GRADE
1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion (ADME)
C) The study of drug toxicity
D) The study of drug interactions
Correct Answer: B
Rationale: Pharmacokinetics is defined as what the body does to the drug and
encompasses the four processes of absorption, distribution, metabolism, and
excretion (ADME). Pharmacodynamics, in contrast, is the study of what the drug
does to the body .
2. The first-pass effect refers to:
A) Rapid intravenous administration
B) Drug metabolism in the liver before reaching systemic circulation (primarily
oral drugs)
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
Correct Answer: B
Rationale: After oral administration, a drug is absorbed from the GI tract and
transported via the portal vein to the liver, where it may be extensively
metabolized before ever reaching the systemic circulation. This is called the first -
pass effect. It reduces the bioavailability of many orally administered drugs .
3. A drug with a half-life of 4 hours is administered every 4 hours. Approximately
how many half-lives are required to reach steady-state concentrations?
A) 1
B) 2
C) 4–5
,D) 8
Correct Answer: C
Rationale: Steady-state is typically achieved after 4-5 half-lives, regardless of the
dosing interval. At that point, the amount of drug eliminated between doses equals
the amount administered. For a 4-hour half-life, steady-state will be reached in
approximately 16-20 hours .
4. Bioavailability refers to:
A) The fraction of a drug eliminated unchanged by the kidneys
B) The time it takes for the drug to reach half its maximum concentration
C) The fraction of an administered dose that reaches systemic circulation
unchanged
D) The rate at which a drug binds to its receptor
Correct Answer: C
Rationale: Bioavailability is a measure of how much of an administered drug dose
actually reaches the systemic circulation. An IV dose has 100% bioavailability
because it enters directly into the bloodstream. Oral drugs typically have lower
bioavailability due to incomplete absorption and first-pass metabolism .
5. A patient with renal impairment is prescribed a medication primarily eliminated
by the kidneys. The nurse anticipates which pharmacokinetic change?
A) Increased absorption
B) Decreased distribution
C) Increased drug half-life
D) Decreased drug half-life
Correct Answer: C
Rationale: Renal impairment reduces the drugs excretion rate. Consequently, the
drug accumulates in the body, leading to a prolonged half-life and an increased risk
of toxicity. Many renally eliminated drugs require dose adjustments based on the
patients estimated glomerular filtration rate (eGFR) .
6. The volume of distribution (Vd) is best described as:
A) The volume of plasma in the body
B) The apparent volume into which a drug distributes
C) The volume of blood filtered by the kidneys
D) The volume of the liver
Correct Answer: B
Rationale: The volume of distribution is an apparent volume that relates the
amount of drug in the body to the plasma concentration. A high Vd indicates
,extensive tissue binding and distribution, while a low Vd indicates that the drug
remains primarily in the plasma .
7. A drug with a high volume of distribution (e.g., digoxin) is characterized by:
A) High plasma concentration
B) Low plasma concentration (distributes widely into tissues)
C) Rapid renal excretion
D) Minimal tissue binding
Correct Answer: B
Rationale: High Vd means most drug is in tissues, not plasma. This requires large
loading doses to achieve therapeutic plasma levels .
8. A patient with hepatic cirrhosis has reduced metabolism of a drug that
undergoes extensive first-pass metabolism. The nurse expects:
A) Reduced drug bioavailability
B) Increased drug bioavailability
C) No change in bioavailability
D) Decreased drug half-life
Correct Answer: B
Rationale: First-pass metabolism occurs in the liver. Impaired liver function
reduces metabolism, increasing bioavailability and the risk of toxicity .
9. Which factor most significantly affects the distribution of a highly protein-
bound drug?
A) Hepatic blood flow
B) Serum albumin levels
C) Renal function
D) Gastric pH
Correct Answer: B
Rationale: Serum albumin levels affect the distribution of highly protein-bound
drugs. Decreased albumin (e.g., in malnutrition, liver disease, nephrotic syndrome)
increases the free drug concentration, potentially leading to toxicity .
10. Cytochrome P450 (CYP) enzymes are primarily located in which organ?
A) Kidney
B) Liver
C) Lungs
D) Intestine
Correct Answer: B
, Rationale: CYP enzymes (e.g., CYP3A4, 2D6, 2C9) are concentrated in the liver
and are responsible for phase I drug metabolism .
11. Which CYP enzyme is responsible for metabolizing the largest number of
drugs?
A) CYP2D6
B) CYP1A2
C) CYP3A4
D) CYP2C9
Correct Answer: C
Rationale: CYP3A4 metabolizes approximately 50% of all drugs, including statins,
calcium channel blockers, and many others .
12. A patient taking warfarin (CYP2C9 substrate) starts taking amiodarone
(CYP2C9 inhibitor). The expected effect is:
A) Decreased warfarin levels
B) Increased warfarin levels (risk of bleeding)
C) No change in warfarin levels
D) Increased warfarin metabolism
Correct Answer: B
Rationale: Amiodarone inhibits CYP2C9, decreasing warfarin metabolism, leading
to increased INR and bleeding risk .
13. A patient who is a poor metabolizer of CYP2D6 (approximately 10% of the
population) takes codeine (a prodrug that requires conversion to morphine by
CYP2D6). The expected effect is:
A) Enhanced analgesic effect
B) No analgesic effect (ineffective conversion)
C) Toxic levels of codeine
D) Rapid metabolism of codeine
Correct Answer: B
Rationale: Codeine is a prodrug that depends on CYP2D6 to be metabolized into
its active form, morphine. Poor metabolizers lack sufficient CYP2D6 enzyme
activity, resulting in minimal conversion of codeine to morphine and thus little to
no analgesic benefit .
14. A drug that binds to a receptor and activates it to produce a full biological
response is classified as a(n):
A) Antagonist
B) Partial agonist
QUESTIONS AND VERIFIED ANSWERS WITH RATIONALES
ALREADY A+ GRADE
1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion (ADME)
C) The study of drug toxicity
D) The study of drug interactions
Correct Answer: B
Rationale: Pharmacokinetics is defined as what the body does to the drug and
encompasses the four processes of absorption, distribution, metabolism, and
excretion (ADME). Pharmacodynamics, in contrast, is the study of what the drug
does to the body .
2. The first-pass effect refers to:
A) Rapid intravenous administration
B) Drug metabolism in the liver before reaching systemic circulation (primarily
oral drugs)
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
Correct Answer: B
Rationale: After oral administration, a drug is absorbed from the GI tract and
transported via the portal vein to the liver, where it may be extensively
metabolized before ever reaching the systemic circulation. This is called the first -
pass effect. It reduces the bioavailability of many orally administered drugs .
3. A drug with a half-life of 4 hours is administered every 4 hours. Approximately
how many half-lives are required to reach steady-state concentrations?
A) 1
B) 2
C) 4–5
,D) 8
Correct Answer: C
Rationale: Steady-state is typically achieved after 4-5 half-lives, regardless of the
dosing interval. At that point, the amount of drug eliminated between doses equals
the amount administered. For a 4-hour half-life, steady-state will be reached in
approximately 16-20 hours .
4. Bioavailability refers to:
A) The fraction of a drug eliminated unchanged by the kidneys
B) The time it takes for the drug to reach half its maximum concentration
C) The fraction of an administered dose that reaches systemic circulation
unchanged
D) The rate at which a drug binds to its receptor
Correct Answer: C
Rationale: Bioavailability is a measure of how much of an administered drug dose
actually reaches the systemic circulation. An IV dose has 100% bioavailability
because it enters directly into the bloodstream. Oral drugs typically have lower
bioavailability due to incomplete absorption and first-pass metabolism .
5. A patient with renal impairment is prescribed a medication primarily eliminated
by the kidneys. The nurse anticipates which pharmacokinetic change?
A) Increased absorption
B) Decreased distribution
C) Increased drug half-life
D) Decreased drug half-life
Correct Answer: C
Rationale: Renal impairment reduces the drugs excretion rate. Consequently, the
drug accumulates in the body, leading to a prolonged half-life and an increased risk
of toxicity. Many renally eliminated drugs require dose adjustments based on the
patients estimated glomerular filtration rate (eGFR) .
6. The volume of distribution (Vd) is best described as:
A) The volume of plasma in the body
B) The apparent volume into which a drug distributes
C) The volume of blood filtered by the kidneys
D) The volume of the liver
Correct Answer: B
Rationale: The volume of distribution is an apparent volume that relates the
amount of drug in the body to the plasma concentration. A high Vd indicates
,extensive tissue binding and distribution, while a low Vd indicates that the drug
remains primarily in the plasma .
7. A drug with a high volume of distribution (e.g., digoxin) is characterized by:
A) High plasma concentration
B) Low plasma concentration (distributes widely into tissues)
C) Rapid renal excretion
D) Minimal tissue binding
Correct Answer: B
Rationale: High Vd means most drug is in tissues, not plasma. This requires large
loading doses to achieve therapeutic plasma levels .
8. A patient with hepatic cirrhosis has reduced metabolism of a drug that
undergoes extensive first-pass metabolism. The nurse expects:
A) Reduced drug bioavailability
B) Increased drug bioavailability
C) No change in bioavailability
D) Decreased drug half-life
Correct Answer: B
Rationale: First-pass metabolism occurs in the liver. Impaired liver function
reduces metabolism, increasing bioavailability and the risk of toxicity .
9. Which factor most significantly affects the distribution of a highly protein-
bound drug?
A) Hepatic blood flow
B) Serum albumin levels
C) Renal function
D) Gastric pH
Correct Answer: B
Rationale: Serum albumin levels affect the distribution of highly protein-bound
drugs. Decreased albumin (e.g., in malnutrition, liver disease, nephrotic syndrome)
increases the free drug concentration, potentially leading to toxicity .
10. Cytochrome P450 (CYP) enzymes are primarily located in which organ?
A) Kidney
B) Liver
C) Lungs
D) Intestine
Correct Answer: B
, Rationale: CYP enzymes (e.g., CYP3A4, 2D6, 2C9) are concentrated in the liver
and are responsible for phase I drug metabolism .
11. Which CYP enzyme is responsible for metabolizing the largest number of
drugs?
A) CYP2D6
B) CYP1A2
C) CYP3A4
D) CYP2C9
Correct Answer: C
Rationale: CYP3A4 metabolizes approximately 50% of all drugs, including statins,
calcium channel blockers, and many others .
12. A patient taking warfarin (CYP2C9 substrate) starts taking amiodarone
(CYP2C9 inhibitor). The expected effect is:
A) Decreased warfarin levels
B) Increased warfarin levels (risk of bleeding)
C) No change in warfarin levels
D) Increased warfarin metabolism
Correct Answer: B
Rationale: Amiodarone inhibits CYP2C9, decreasing warfarin metabolism, leading
to increased INR and bleeding risk .
13. A patient who is a poor metabolizer of CYP2D6 (approximately 10% of the
population) takes codeine (a prodrug that requires conversion to morphine by
CYP2D6). The expected effect is:
A) Enhanced analgesic effect
B) No analgesic effect (ineffective conversion)
C) Toxic levels of codeine
D) Rapid metabolism of codeine
Correct Answer: B
Rationale: Codeine is a prodrug that depends on CYP2D6 to be metabolized into
its active form, morphine. Poor metabolizers lack sufficient CYP2D6 enzyme
activity, resulting in minimal conversion of codeine to morphine and thus little to
no analgesic benefit .
14. A drug that binds to a receptor and activates it to produce a full biological
response is classified as a(n):
A) Antagonist
B) Partial agonist
